News Releases

Oct. 25, 2002

Emory Eye Center researchers identify lymphocytes required for Ocular Tolerance

(ATLANTA) Unlike other parts of the body, the eye will tolerate the presence of foreign tissue in certain areas, such as the anterior chamber between the iris and the cornea, or the space underneath the retina. The same tissue placed elsewhere in the body, on the skin for example, would trigger an immune reaction and be rejected. Researchers at the Emory University School of Medicine in Atlanta, Ga., have studied this unique ability of the eye to develop methods to inhibit rejection by selectively enhancing immunological unresponsiveness, or “tolerance.” Yijun Xu, PhD and Judith A. Kapp, PhD, of the departments of Ophthalmology, Pathology and Winship Cancer Center, reported the results of their work in the November issue of Investigative Ophthalmology and Visual Science.
The major problem with any organ or tissue transplantation is that the recipient usually rejects cells from another person unless they are twins. The recipient’s immune system does not distinguish between a transplanted retinal cell, for example, or an invading microorganism, such as bacteria and viruses. Inflammation is the body’s way of fighting infection as the white blood cells, called lymphocytes, and antibodies attack and destroy antigens carried by the “invader.” In the eye, inflammation may result in excessive tissue damage that could lead to blindness.

Drs. Xu and Kapp are studying how a phenomenon called Anterior Chamber-Associated Immune Deviation or ACAID by its initials, combats inflammation. ACAID occurs when the hypersensitivity of the eye against an invader is reduced with administration of an antigen, thereby decreasing the risk of sight-threatening inflammation.
Studies with mice have shown that by delivering a certain antigen, the white blood cells can be neutralized and their ability to produce antibodies reduced. Delivery of a soluble form of antigen into the anterior chamber of the eye of anesthetized mice triggered the ACAID phenomenon, decreasing the hypersensitivity in the eye and throughout the body.
The technique requires certain specific white blood cells, called (gamma delta) T cells, as Drs. Xu and Kapp learned. In otherwise normal mice, which did not have a sufficient quantity of T cells, the immune response could not be inhibited. This led the Emory scientists to conclude that ocular tolerance depends upon the participation of these special lymphocytes. Understanding how T cells affect tolerance may one day be used to prevent graft rejection and to provide novel treatments for patients with autoimmune diseases.
Contact: Judith A. Kapp, PhD, Department of Ophthalmology, Emory University School of Medicine, Building. B, Room 2602, 1635 Clifton Road, NE, Atlanta, GA 30322 (tel: 404-778-4754; fax: 404-778-2109; e-mail: jkapp@emory.edu)

Media Contact: Joy H. Bell
jbell@emory.edu
404-778-3711

Our Emory campus location:

Copyright © Emory Eye Center - All Rights Reserved | Emory Clinic Building B, 1365B Clifton Road, NE, Atlanta, Georgia 30322 USA